Furthermore, we testified that inhibition of screened miR-4454 and miR-4454 inhibitor-mediated exosomes could inhibit HCC progression by targeting Vps4A and Rab27A (Figure 11). The gene discussed is RAB27A; the disease is hepatocellular carcinoma.